Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5011 AL 5025

[Dementia guidelines: what should come to general practice--an interdisciplinary consensus of physicians in private practice]

Riepe MW, Fellgiebel A; DEGAM, DGN, DGPPN.

Dtsch Med Wochenschr. 2012 Jul;137(30):1499-504. doi: 10.1055/s-0032-1305171. Epub 2012 Aug 6.

Biomarkers for dementia diagnosis: differentiating DLB and FTD may be difficult

Aarsland D, Ballard CG.

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1037. doi: 10.1136/jnnp-2012-303026. Epub 2012 Aug 6.

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S, Shiovitz T, Pilcher G, Colby S, Rollin L, Dockens R, Pachai C, Portelius E, Andreasson U, Blennow K, Soares H, Albright C, Feldman HH, Berman RM.

Arch Neurol. 2012 Nov;69(11):1430-40. doi: 10.1001/archneurol.2012.2194.

Origins of delusions in Alzheimer's disease

Reeves SJ, Gould RL, Powell JF, Howard RJ.

Neurosci Biobehav Rev. 2012 Nov;36(10):2274-87. doi: 10.1016/j.neubiorev.2012.08.001. Epub 2012 Aug 11.

Alzheimer's disease and euthanasia

Alvargonzález D.

J Aging Stud. 2012 Dec;26(4):377-85. doi: 10.1016/j.jaging.2012.04.001. Epub 2012 May 9.

[Diagnosis and treatment of mixed dementia]

Hanyu H.

Brain Nerve. 2012 Sep;64(9):1047-55.

Assessing the impact and social perception of self-regulated music stimulation with patients with Alzheimer's disease

Lancioni GE, O'Reilly MF, Singh NN, Sigafoos J, Grumo G, Pinto K, Stasolla F, Signorino M, Groeneweg J.

Res Dev Disabil. 2013 Jan;34(1):139-46. doi: 10.1016/j.ridd.2012.07.026. Epub 2012 Sep 1.

Cerebral hypoperfusion and white matter disease in healthy elderly and patients with Alzheimer's disease

Gurol ME.

Eur J Neurol. 2013 Feb;20(2):214-5. doi: 10.1111/j.1468-1331.2012.03865.x. Epub 2012 Sep 9.

The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results

Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E.

J Neurol Sci. 2012 Nov 15;322(1-2):96-101. doi: 10.1016/j.jns.2012.07.003. Epub 2012 Sep 7.

NAPA 2.0: the next giant leap

Khachaturian AS, Paul SM, Khachaturian ZS.

Alzheimers Dement. 2012 Sep;8(5):379-80. doi: 10.1016/j.jalz.2012.08.002.

Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year

Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, Cotman CW.

Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):96-103. doi: 10.1016/j.archger.2012.06.016. Epub 2012 Sep 5.

Technology-based orientation programs to support indoor travel by persons with moderate Alzheimer's disease: impact assessment and social validation

Lancioni GE, Perilli V, O'Reilly MF, Singh NN, Sigafoos J, Bosco A, Caffò AO, Picucci L, Cassano G, Groeneweg J.

Res Dev Disabil. 2013 Jan;34(1):286-93. doi: 10.1016/j.ridd.2012.08.016. Epub 2012 Sep 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias